Lonza Acquires Roche's US Commercial Biologics Manufacturing Site for $1.2 Billion

Retrieved on: 2024-03-25 15:49:59

Tags for this article:

Biotechnology

Biopharmaceutical

Pharmaceutical industry

Pharmacy

Contract manufacturing organization

Vacaville, California

Portsmouth, New Hampshire

Lonza Group

Lonza company

Click the tags to see associated articles and topics

Lonza Acquires Roche's US Commercial Biologics Manufacturing Site for $1.2 Billion. View article details on HISWAI: https://www.biopharminternational.com/view/lonza-acquires-roche-s-us-commercial-biologics-manufacturing-site-for-1-2-billion

Excerpt

Lonza announced on March 20, 2024 that is has signed an agreement to acquire from Roche its Vacaville, Calif., site, a large-scale biologics ...

Article found on: www.biopharminternational.com

View Original Article